# Left Atrial Thrombus and Cardioembolic Stroke in Chagas Cardiomyopathy Presenting with Atrial Flutter: A Case Report

**Authors:** Mauricio Sebastián Moreno-Bejarano, Israel Silva-Patiño, Andrea Cristina Aragón-Jácome, Juan Esteban Aguilar, Ana Sofía Cepeda-Zaldumbide, Angela Velez-Reyes, Camila Salazar-Santoliva, Jorge Vasconez-Gonzalez, Juan S. Izquierdo-Condoy, Esteban Ortiz-Prado

PMC · DOI: 10.3390/jcm15020456 · 2026-01-07

## TL;DR

A patient with Chagas disease developed a rare combination of heart issues and stroke, but recovered well with prompt treatment.

## Contribution

This case report highlights the rare coexistence of Chagas cardiomyopathy, atrial flutter, and cardioembolic stroke due to left atrial thrombus.

## Key findings

- The patient showed rapid neurological improvement after thrombolysis and anticoagulation.
- Multidisciplinary management and early recognition led to a favorable outcome.
- Chagas cardiomyopathy can present with atrial flutter and left atrial thrombus causing stroke.

## Abstract

Background: Chagas disease, caused by Trypanosoma cruzi, remains endemic throughout Latin America but is increasingly reported in urban areas due to migration and vector adaptation. The cardiac form is the most severe manifestation, associated with arrhythmia, mural thrombus formation, and a high risk of cardioembolic events. Stroke secondary to Chagas cardiomyopathy is uncommon and poses diagnostic and therapeutic challenges. Case Presentation: A 58-year-old woman with serologic evidence of T. cruzi infection presented with sudden-onset dyspnea, oppressive chest pain, and left-sided weakness. Neurological examination revealed left brachiocrural hemiparesis and mild dysarthria (NIHSS = 9). Non-contrast cranial CT showed an acute infarct in the right middle cerebral artery territory (ASPECTS = 7). Electrocardiography demonstrated typical atrial flutter with variable conduction, and transthoracic echocardiography revealed a markedly dilated left atrium containing a mural thrombus and a left ventricular ejection fraction of 45%. Intravenous thrombolysis with alteplase (0.9 mg/kg) was administered within 4.5 h of symptom onset. Pharmacologic rhythm control was achieved using intravenous and oral amiodarone, followed by oral anticoagulation with warfarin (target INR 2.0–3.0) after excluding hemorrhagic transformation. The patient showed rapid neurological improvement (NIHSS reduction from 9 to 2) and was discharged on day 10 with minimal residual deficit (mRS = 1), sinus rhythm, and stable hemodynamics. Conclusions: This case highlights the rare coexistence of Chagas cardiomyopathy, atrial flutter, and cardioembolic stroke due to left atrial thrombus. Early recognition, adherence to evidence-based guidelines, and multidisciplinary management were key to achieving a favorable outcome. Timely diagnosis and intervention remain crucial to preventing severe complications in patients with Chagas disease.

## Linked entities

- **Chemicals:** amiodarone (PubChem CID 2157), warfarin (PubChem CID 54678486)
- **Diseases:** Chagas disease (MONDO:0001444), Chagas cardiomyopathy (MONDO:0005491)
- **Species:** Trypanosoma cruzi (taxon 5693)

## Full-text entities

- **Diseases:** Cardioembolic Stroke (MESH:D000083262), hemorrhagic transformation (MESH:D006470), Atrial Flutter (MESH:D001282), dyspnea (MESH:D004417), Left Atrial Thrombus (MESH:D013927), infarct (MESH:D007238), Stroke (MESH:D020521), Chagas Cardiomyopathy (MESH:D002598), Chagas disease (MESH:D014355), arrhythmia (MESH:D001145), dysarthria (MESH:D004401), hemiparesis (MESH:D010291), chest pain (MESH:D002637), weakness (MESH:D018908)
- **Chemicals:** amiodarone (MESH:D000638), warfarin (MESH:D014859)
- **Species:** Homo sapiens (human, species) [taxon 9606], Trypanosoma cruzi (species) [taxon 5693]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12842116/full.md

---
Source: https://tomesphere.com/paper/PMC12842116